Abstract
The complementary roles fulfilled by observational studies and randomized controlled trials in the population science research agenda is illustrated using results from the Women’s Health Initiative (WHI). Comparative and joint analyses of clinical trial and observational study data can enhance observational study design and analysis choices, and can augment randomized trial implications. These concepts are described in the context of findings from the WHI randomized trials of postmenopausal hormone therapy and of a low-fat dietary pattern, especially in relation to coronary heart disease, stroke, and breast cancer. The role of biomarkers of exposure and outcome, including high-dimensional genomic and proteomic biomarkers, in the elucidation of disease associations, will also be discussed in these same contexts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrett-Conner E and Grady D (1998). Hormone replacement therapy, heart disease and other considerations. Annu Rev Public Health 19: 55–72
Bingham SA, Luben R, Welch A, Wareham N, Khaw KT and Day N (2003). Are imprecise methods obscuring a relationship between fat and breast cancer?. Lancet 362: 212–214
Breslow NE, Day NE (1980) Statistical methods in cancer research—the analysis of case-control studies, vol 1. IARC Scientific Publications 32, International Agency for Research on Cancer, Lyon, France
Breslow NE, Day NE (1987) Statistical methods in cancer research—the design and analysis of cohort studies, vol 2. IARC Scientific Publications 32, International Agency for Research on Cancer, Lyon, France
Carroll RJ, Freedman L, Kipnis V and Li L (1998). A new class of measurement error models, with application to dietary data. Can J Stat 26: 467–477
Cox DR (1972). Regression models and life tables (with discussion). J Royal Statistical Soc B 34: 187–220
Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, Troiano RP, Prentice R, Patterson R, Carroll R and Subar AF (2006). A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int. J. Epidemiol. 35(4): 1011–1021, [Epub May 3, 2006]
Heitmann BL and Lissner L (1995). Dietary underreporting by obese individuals—is it specific or non-specific? Br Med J 311: 986–989
Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, Lubin F, Marubini E, Modan B and Rohan T et al (1990). Dietary factors and risk of breast cancer: combined analysis of 12 case–control studies. J Nat Cancer Inst 82: 561–569
Hunter D, Spiegelman D, Adami H-O, Beeson L, van den Brandt PA, Folsom AR, Fraser GE, Goldbohm RA, Graham S and Howe GR et al (1996). Cohort studies of fat intake and the risk of breast cancer—a pooled analysis. New England J Med 334: 356–361
Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR and Blanchette P et al (2006). The Women’s Health Initiative trial of calcium plus vitamin D supplementation on risk for fractures. N Engl J Med 354: 669–683
Prentice RL (1996). Measurement error and results from analytic epidemiology: dietary fat and breast cancer. J Nat Cancer Inst 88(23): 1738–1747
Prentice RL, Caan B, Chlebowski R, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE and Parker LM et al (2006). Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative randomized controlled dietary modification trial. J Am Med Assoc 295: 629–642
Prentice RL, Pettinger M and Anderson GL (2005a). Statistical issues arising in the Women’s Health Initiative (with discussion). Biometrics 61: 899–941
Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M and Wactawski-Wende J (2005). Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women’s Health Initiative clinical trial. Am J Epidemiol 162: 1–11
Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M and Wactawski-Wende J (2006). Combined analysis of Women’s Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol 163(7): 589–599
Prentice RL and Qi L (2006). Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation. Biostatistics 7: 339–354
Prentice RL and Sheppard L (1990). Feasibility and importance of clinical trials of a low fat diet to reduce cancer risk. Prog Clin Biol Res 346: 205–215
Prentice RL, Sugar E, Wang CY, Neuhouser M and Patterson R (2002). Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease. Public Health Nutr 5: 977–984
Shaw P (2006) Estimation methods for Cox regression with nonclassical measurement error. Doctoral Dissertation Department of Biostatistics, University of Washington
Stampfer M and Colditz G (1991). Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20: 47–63
Sugar EA, Wang CY and Prentice RL (2007). Logistic regression with exposure biomarkers and flexible measurement error. Biometrics 63: 143–151
Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, M. J. O’Sullivan, Margolis KL, Ockene JK, Phillips L and Pottern L et al (2006). Calcium, vitamin D supplementation and colorectal cancer in postmenopausal women: the Women’s Health Initiative clinical trial. N Eng J Med 354: 684–696
Wang H, Clouthier SG, Galchev V, Misek DE, Duffner U, Min CK, Zhao R, Tra J, Omenn GS, Ferrara JL and Hanash SM (2005). Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol and Cell Proteomics 4: 618–625
Women’s Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. J Am Med Assoc 291(14): 1701–1712
Women’s Health Initiative Study Group (1998). Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19: 61–109
Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 288: 321–333
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prentice, R.L. Observational studies, clinical trials, and the women’s health initiative. Lifetime Data Anal 13, 449–462 (2007). https://doi.org/10.1007/s10985-007-9047-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10985-007-9047-z